BDXB — Becton Dickinson and Co Share News
0.000.00%
Last trade - 00:00- $71.51bn
- $87.75bn
- $18.87bn
U.S. STOCKS ON THE MOVE-Arrow Electronics, fintechs, Amazon.com,
U.S. STOCKS ON THE MOVE-Aptiv, NRx Pharma, Becton Dickinson
Becton Dickinson up on upbeat FY23 forecast
Becton Dickinson and Co reports results for the quarter ended in December - Earnings Summary
Brief: BD Reports First Quarter Fiscal 2023 Financial Results
Brief: Becton Dickinson Reports Q1 revenue $4,600 Mln
Becton Dickinson and Co expected to post earnings of $2.68 a share - Earnings Preview
Brief: Bd & Unit Entered Into Certain Second Amended And Restated Credit Agreement
Brief: Becton Dickinson Announce Emergency Use Authorization For Mpox Diagnostic Test
Brief: Michelle Quinn Named Acting General Counsel For BD
Brief: Becton Dickinson Says CEO's 2022 Compensation Was $16.7 Mln
Medical device makers may see recovery in 2023 - Citi
NYSE ORDER IMBALANCE 278652.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 50573.0 SHARES ON BUY SIDE
AngioDynamics falls as jury finds it violated Becton Dickinson patents
NYSE ORDER IMBALANCE 182926.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 91767.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 73631.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-Expensify, NVIDIA, Signature Bank